WallStreetZenWallStreetZen

NASDAQ: QNCX
Quince Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Quince Therapeutics earnings were -$60.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest QNCX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$15.0M, up 20.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, QNCX reported annual earnings of -$56.8M, with 81.1% growth.

QNCX earnings history

Current Revenue
$0.0
Current Earnings
-$60.7M
Current Profit Margin
0%

QNCX Return on Equity

Current Company
-172.7%
Current Industry
-60.2%
Current Market
31.5%
QNCX's Return on Equity (-172.7%)... subscribe to Premium to read more.
High Return on Equity Performance

QNCX undefined

Current Company
-50.3%
Current Industry
-2.5%
QNCX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when QNCX announces earnings.

QNCX undefined

Current Company
-61.38%
Current Industry
5.8%
QNCX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

QNCX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
QNCX-$60.43M-$60.71MN/A-$1.39
IKNA-$39.06M-$41.71MN/A-$0.86
ABOS-$111.98M-$116.25MN/A-$1.94
MNOV-$10.96M-$11.16MN/A-$0.23
ANRO-$60.53M-$63.18MN/A-$2.34
View Top Biotech Stocks

Quince Therapeutics Earnings Reports & History FAQ

What were Quince Therapeutics's earnings last quarter?

On QNCX's earnings call on Invalid Date, Quince Therapeutics (NASDAQ: QNCX) reported Q1 2025 earnings per share (EPS) of -$0.34, up 30.77% year over year. Total QNCX earnings for the quarter were -$15.03 million. In the same quarter last year, Quince Therapeutics's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Quince Therapeutics stock.

Is Quince Therapeutics profitable or losing money?

As of the last Quince Therapeutics earnings report, Quince Therapeutics is currently losing money. Quince Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$60.71 million, a 100.49% increase year over year.

What was QNCX's earnings growth in the past year?

As of Quince Therapeutics's earnings date in Invalid Date, Quince Therapeutics's earnings has grown year over year. QNCX earnings in the past year totalled -$60.71 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.